Literature DB >> 21193946

Evaluation of venous thromboembolism risk following hospitalization.

Sheryl J Herner1, Dwight C Paulson, Thomas Delate, Daniel M Witt, Thomas G Vondracek.   

Abstract

UNLABELLED: A better understanding of the relationship between outpatient venous thromboembolism (VTE) and prior hospitalization is needed including data regarding the utilization of inpatient pharmacologic VTE prophylaxis and its effect on outpatient venous thromboembolic risk. The primary objective was to assess the association between development of outpatient VTE and inpatient hospitalization within the previous 90 days. Additional outcome measures included describing patients who received pharmacologic anticoagulation during hospitalization and identification of factors independently associated with VTE. Case patients in this matched case-control study were diagnosed with an outpatient deep vein thrombosis or pulmonary embolus between January 2005 and December 2007 and were matched on age with up to five to patients who were seen for an outpatient health maintenance visit but had no VTE during the same time frame as their matched case. Information collected from electronic administrative databases and patient medical records included health services utilization, medication use, medical diagnoses, and patient demographic information. Of 2190 cases, 560 patients (25.6%) compared to 151 (1.4%) of 10,942 control patients were hospitalized in the previous 90 days (P < 0.001). Among hospitalized patients, 53.5% of cases and 47.0% of controls received an anticoagulant during hospitalization (P = 0.186). Factors associated with a VTE diagnosis included hospitalization for a surgical, medical, or orthopedic indication in the previous 90 days, younger age, longer hospitalization, cancer and an elevated Chronic Disease Score.
CONCLUSIONS: A strong association exists between outpatient VTE diagnosis and hospitalization and gaps in pharmacologic prophylaxis utilization during hospitalization are evident.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21193946     DOI: 10.1007/s11239-010-0542-9

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  20 in total

1.  Outcomes and predictors of very stable INR control during chronic anticoagulation therapy.

Authors:  Daniel M Witt; Thomas Delate; Nathan P Clark; Chad Martell; Thu Tran; Mark A Crowther; David A Garcia; Walter Ageno; Elaine M Hylek
Journal:  Blood       Date:  2009-05-13       Impact factor: 22.113

Review 2.  Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.

Authors:  R D Hull; G F Pineo; P D Stein; A F Mah; S M MacIsaac; O E Dahl; M Butcher; R F Brant; W A Ghali; D Bergqvist; G E Raskob
Journal:  Ann Intern Med       Date:  2001-11-20       Impact factor: 25.391

3.  Use of managed care claims data in the risk assessment of venous thromboembolism in outpatients.

Authors:  Mason W Russell; Douglas C A Taylor; Gordon Cummins; Daniel M Huse
Journal:  Am J Manag Care       Date:  2002-01       Impact factor: 2.229

4.  Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.

Authors:  David Bergqvist; Giancarlo Agnelli; Alexander T Cohen; Amiram Eldor; Paul E Nilsson; Anne Le Moigne-Amrani; Flavia Dietrich-Neto
Journal:  N Engl J Med       Date:  2002-03-28       Impact factor: 91.245

5.  Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy.

Authors:  Daniel M Witt; Melanie A Sadler; Roberta L Shanahan; Georgann Mazzoli; Donald J Tillman
Journal:  Chest       Date:  2005-05       Impact factor: 9.410

6.  A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.

Authors:  Diane N Wiseman; Jeff Harrison
Journal:  N Z Med J       Date:  2010-02-19

7.  Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study.

Authors:  John A Heit; W Michael O'Fallon; Tanya M Petterson; Christine M Lohse; Marc D Silverstein; David N Mohr; L Joseph Melton
Journal:  Arch Intern Med       Date:  2002-06-10

8.  Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey.

Authors:  Jean-Francois Bergmann; Alexander T Cohen; Victor F Tapson; Samuel Z Goldhaber; Ajay K Kakkar; Bruno Deslandes; Wei Huang; Frederick A Anderson
Journal:  Thromb Haemost       Date:  2010-02-02       Impact factor: 5.249

9.  Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  William H Geerts; David Bergqvist; Graham F Pineo; John A Heit; Charles M Samama; Michael R Lassen; Clifford W Colwell
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

10.  Venous thromboembolism in the outpatient setting.

Authors:  Frederick A Spencer; Darleen Lessard; Cathy Emery; George Reed; Robert J Goldberg
Journal:  Arch Intern Med       Date:  2007-07-23
View more
  1 in total

1.  Hospitalizations of adults ≥60 years of age with venous thromboembolism.

Authors:  Hussain R Yusuf; Nimia Reyes; Qing C Zhang; Ekwutosi M Okoroh; Azfar-E-Alam Siddiqi; James Tsai
Journal:  Clin Appl Thromb Hemost       Date:  2013-06-27       Impact factor: 2.389

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.